Literature DB >> 6971627

IgG antiglobulins in rheumatoid arthritis and other arthritides: relationship with clinical features and other parameters.

C Allen, C J Elson, D G Scott, P A Bacon, R C Bucknall.   

Abstract

A radioimmunoassay has been developed for measuring IgG antiglobulins using baboon IgG as antigen. Raised levels were virtually confined to the sera of patients with rheumatoid arthritis (RA) and not found in other seronegative arthritides. High levels were found in both seropositive and seronegative (as judged by latex slide and sheep cell differential agglutination for IgM antiglobulins) patients with RA and were associated with systemic disease but not synovitis. Very high levels (more than twice the upper limit of normal) showed a strong association with vasculitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971627      PMCID: PMC1000693          DOI: 10.1136/ard.40.2.127

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  The use of baboon IgG-sensitized sheep erythrocytes as an alternative indicator system in the study of the interaction of rheumatoid factor with human IgG.

Authors:  G A Stewart; I M Hunneyball; D R Stanworth
Journal:  Immunochemistry       Date:  1975-08

2.  IgG antiglobulin levels in patients with psoriatic arthropathy, ankylosing spondylitis, and gout.

Authors:  F A Howell; M A Chamberlain; R A Perry; G Torrigiani; I M Roitt
Journal:  Ann Rheum Dis       Date:  1972-03       Impact factor: 19.103

3.  IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis.

Authors:  A N Theofilopoulos; G Burtonboy; J J LoSpalluto; M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

4.  General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice.

Authors:  N R Klinman; R B Taylor
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

5.  Antiglobulins in ankylosing spondylitis.

Authors:  R M Arana; M T de la Vega; A Porrini; O Garcia Morteo
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

6.  Intermediate complexes formed by self-association of IgG-rheumatoid factors.

Authors:  R M Pope; D C Teller; M Mannik
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

7.  The quantitation of rheumatoid factors.

Authors:  D J Lea; D J Ward
Journal:  Arthritis Rheum       Date:  1972 Nov-Dec

8.  Routine assay for detection of IgG and IgM antiglobulins in seronegative and seropositive rheumatoid arthritis.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Br Med J       Date:  1975-07-26

9.  Rheumatoid factor-producing cells detected by direct hemolytic plaque assay.

Authors:  J H Vaughan; T Chihara; T L Moore; D L Robbins; K Tanimoto; J S Johnson; R McMillan
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  IgG rheumatoid factor. Relationship to seropositive rheumatoid arthritis and absence in seronegative disorders.

Authors:  R M Pope; S J McDuffy
Journal:  Arthritis Rheum       Date:  1979-09
View more
  21 in total

1.  Antibody producing capacity to the bacteriophage phi X174 in rheumatoid arthritis.

Authors:  R Bucknall; P Bacon; C Elson; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

2.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

3.  A new assay for IgG rheumatoid factor activity and its use to analyse rheumatoid factor reactivity with human IgG isotypes.

Authors:  C J Elson; S D Carter; D G Scott; P A Bacon; J Lowe
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

4.  Enzyme immunoassay of complement-binding rheumatoid factors.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

5.  Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.

Authors:  J L Bampton; T E Cawston; M V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

6.  Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.

Authors:  C J Elson; S D Carter; B J Cottrell; D G Scott; P A Bacon; T B Wallington
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

7.  Continuous production of anti-host IgG antibodies contained in circulating IgG-anti-IgG complexes.

Authors:  S A Grace; C J Elson
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

8.  Clinical and immunogenetic studies in rheumatoid arthritis from northern India.

Authors:  A N Malaviya; N K Mehra; B Dasgupta; K M Khan; U R Rao; A Agarwal; S C Tiwari
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

9.  IgG and IgM rheumatoid factor in active seronegative nodular rheumatoid arthritis and in children with benign rheumatoid nodules.

Authors:  D L Robbins; T L Moore; S M Naguwa
Journal:  Clin Rheumatol       Date:  1982-06       Impact factor: 2.980

10.  IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.

Authors:  F P Quismorio; T Beardmore; R L Kaufman; E S Mongan
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.